Assertio Therapeutics (NASDAQ:ASRT) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.07 by 214.29 percent. This is a 175 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $34.21 million which beat the analyst consensus estimate of $31.33 million by 9.20 percent. This is a 34.31 percent increase over sales of $25.47 million the same period last year.
Caravelle International Group Reprorts FY22 EPS $0.24 Vs $0.11 YoY; Revenue $185.3M Vs $122M YoY
Audited revenue for 2022 of $185.3 million, up from $122.0 million in 2021, marking a 51.9% growth.
Caravelle earned $12.2 million in 2022 vs. $5.3 million in
